1.
Trape G, Fianchi L, Lai M, Laurenti L, Piscitelli R, Leone G, Pagano L. Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders. Haematologica 2003; 88(2):223-225.